Sanofi-Aventis (France) Could Announce Genzyme Corporation Deal Next Week: Report

February 3, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

(Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) could announce a deal to buy U.S. biotech Genzyme (GENZ.O) early next week if final negotiations between the companies go smoothly, Le Figaro reported on Thursday.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions

Sanofi (France)